What is the ticker symbol for Eliem Therapeutics?

Eliem Therapeutics trades under the ticker ELYM on NASDAQ.

What sector does Eliem Therapeutics operate in?

Eliem Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ELYM in a portfolio?

PortView shows ELYM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Eliem Therapeutics (ELYM) Stock Analysis

NASDAQHealthcareBiotechnology

$5.11-0.97%

1-year price historyRange $2.45 – $10.20

52-week range$5.11

$2.35$11.55

What Eliem Therapeutics does

Eliem Therapeutics, Inc. is a clinical-stage biotechnology firm focused on developing therapeutic solutions for conditions characterized by abnormal neuronal excitability. The company aims to fulfill significant unmet medical needs in areas such as chronic pain management, neuropsychiatric illnesses, epilepsy, and other disorders affecting the central and peripheral nervous systems. Their developmental pipeline is highlighted by two primary drug candidates. ETX-810 is currently in Phase IIa clinical studies for the treatment of chronic pain. The second key candidate, ETX-155, is undergoing Phase I clinical trials, with potential applications for major depressive disorder, perimenopausal depression, and focal onset seizures. Beyond these lead assets, Eliem is also cultivating several preclinical programs, including a Kv7 Program targeting pain, epilepsy, and depression, and an Anxiolytic program specifically designed for generalized anxiety disorder. Eliem Therapeutics, Inc. was established in 2018 and is headquartered in Redmond, Washington.

Key metrics

Market cap

$342.68M

P/E (TTM)

-2.30

EPS (TTM)

$-2.22

Beta

-0.38

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$6.46

200-day avg

$5.57

52-week high

$11.55

52-week low

$2.35

CEO

Aoife M. Brennan BAO, BCh, MB, MMSc

ETFs linked to ELYM

Broad-market and Healthcare sector ETFs an investor holding Eliem Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ELYM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ELYM in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Eliem Therapeutics?: Eliem Therapeutics trades under the ticker ELYM on NASDAQ.
Which exchange is ELYM listed on?: ELYM is listed on NASDAQ.
What sector does Eliem Therapeutics operate in?: Eliem Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ELYM in a portfolio?: PortView shows ELYM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.